MediWound (MDWD) Income from Non-Controlling Interests (2013 - 2016)
MediWound's (MDWD) quarterly Income from Non-Controlling Interests came in at $3000.0 in Q2 2016, up 200.0% quarter-over-quarter from $1000.0 in Q4 2015.
MediWound (MDWD) Income from Non-Controlling Interests (2013 - 2016) Analysis & Trends
MediWound's Income from Non-Controlling Interests history runs 4 years deep, the most recent figure standing at $3000.0 for Q2 2016.
- On a quarterly basis, Income from Non-Controlling Interests changed N/A year-over-year to $3000.0 in Q2 2016; TTM through Jun 2016 was $4000.0, a 50.0% decrease from a year earlier, with the FY2015 full-year figure at $2000.0, down 85.71% from the prior year.
- Income from Non-Controlling Interests improved to $3000.0 in Q2 2016 per MDWD's latest filing, from $1000.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $34000.0 in Q3 2014 and bottomed at -$27000.0 in Q4 2014.
- The 4-year median for Income from Non-Controlling Interests is $1000.0 (2015), against an average of -$1444.4.
- Biggest YoY gain for Income from Non-Controlling Interests was 525.0% in 2014; the steepest drop was 12.5% in 2014.
- Year by year, Income from Non-Controlling Interests stood at -$24000.0 in 2013, then decreased by 12.5% to -$27000.0 in 2014, then surged by 103.7% to $1000.0 in 2015, then soared by 200.0% to $3000.0 in 2016.
- Per Business Quant, the three latest MDWD Income from Non-Controlling Interests figures stand at $3000.0 (Q2 2016), $1000.0 (Q4 2015), and $1000.0 (Q1 2015).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | - |
| 2 | Nanobiotix | 1,935.05 Bn | 1,934.98 Bn | - | - |
| 3 | Akari Therapeutics | 1,021.31 Bn | 1,021.31 Bn | - | - |
| 4 | BeOne Medicines | 467.89 Bn | 463.10 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.19 Bn | 61.44 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 63.46 Bn | 63.46 Bn | - | - |
| 8 | Argenx Se | 55.64 Bn | 50.45 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn | - |
| 10 | MediWound | 167.52 Mn | 162.72 Mn | 278,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 3,000.00 |
| Dec 31, 2015 | 1,000.00 |
| Mar 31, 2015 | 1,000.00 |
| Dec 31, 2014 | -27,000.00 |
| Sep 30, 2014 | 34,000.00 |
| Jun 30, 2014 | 17,000.00 |
| Mar 31, 2014 | -10,000.00 |
| Dec 31, 2013 | -24,000.00 |
| Sep 30, 2013 | -8,000.00 |